These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36198471)

  • 21. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.
    Padhani AR; Lecouvet FE; Tunariu N; Koh DM; De Keyzer F; Collins DJ; Sala E; Schlemmer HP; Petralia G; Vargas HA; Fanti S; Tombal HB; de Bono J
    Eur Urol; 2017 Jan; 71(1):81-92. PubMed ID: 27317091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
    Taylor SA; Mallett S; Beare S; Bhatnagar G; Blunt D; Boavida P; Bridgewater J; Clarke CS; Duggan M; Ellis S; Glynne-Jones R; Goh V; Groves AM; Hameeduddin A; Janes SM; Johnston EW; Koh DM; Miles A; Morris S; Morton A; Navani N; O'Donohue J; Oliver A; Padhani AR; Pardoe H; Patel U; Punwani S; Quinn L; Rafiee H; Reczko K; Rockall AG; Shahabuddin K; Sidhu HS; Teague J; Thaha MA; Train M; van Ree K; Wijeyekoon S; Halligan S;
    Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):529-537. PubMed ID: 31080095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Findings in whole body MRI and conventional imaging in patients with fever of unknown origin-a retrospective study.
    Tavakoli AA; Reichert M; Blank T; Dinter D; Weckbach S; Buchheidt D; Schoenberg SO; Attenberger U
    BMC Med Imaging; 2020 Aug; 20(1):94. PubMed ID: 32767967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
    Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
    Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
    Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
    Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.
    Pricolo P; Ancona E; Summers P; Abreu-Gomez J; Alessi S; Jereczek-Fossa BA; De Cobelli O; Nolè F; Renne G; Bellomi M; Padhani AR; Petralia G
    Cancer Imaging; 2020 Oct; 20(1):77. PubMed ID: 33109268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
    Stecco A; Buemi F; Iannessi A; Carriero A; Gallamini A
    Leuk Lymphoma; 2018 Nov; 59(11):2546-2556. PubMed ID: 29431555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.
    Taylor SA; Mallett S; Bhatnagar G; Morris S; Quinn L; Tomini F; Miles A; Baldwin-Cleland R; Bloom S; Gupta A; Hamlin PJ; Hart AL; Higginson A; Jacobs I; McCartney S; Murray CD; Plumb AA; Pollok RC; Rodriguez-Justo M; Shabir Z; Slater A; Tolan D; Travis S; Windsor A; Wylie P; Zealley I; Halligan S
    Health Technol Assess; 2019 Aug; 23(42):1-162. PubMed ID: 31432777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.
    Almeida SD; Santinha J; Oliveira FPM; Ip J; Lisitskaya M; Lourenço J; Uysal A; Matos C; João C; Papanikolaou N
    Cancer Imaging; 2020 Jan; 20(1):6. PubMed ID: 31931880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
    Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
    Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Dyrberg E; Hendel HW; Huynh THV; Klausen TW; Løgager VB; Madsen C; Pedersen EM; Pedersen M; Thomsen HS
    Eur Radiol; 2019 Mar; 29(3):1221-1230. PubMed ID: 30132104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including
    Latifoltojar A; Punwani S; Lopes A; Humphries PD; Klusmann M; Menezes LJ; Daw S; Shankar A; Neriman D; Fitzke H; Clifton-Hadley L; Smith P; Taylor SA
    Eur Radiol; 2019 Jan; 29(1):202-212. PubMed ID: 29948084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-body magnetic resonance imaging (WB-MRI) in oncology: an Italian survey.
    Albano D; Stecco A; Micci G; Sconfienza LM; Colagrande S; Reginelli A; Grassi R; Carriero A; Midiri M; Lagalla R; Galia M
    Radiol Med; 2021 Feb; 126(2):299-305. PubMed ID: 32572763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS).
    Messiou C; Hillengass J; Delorme S; Lecouvet FE; Moulopoulos LA; Collins DJ; Blackledge MD; Abildgaard N; Østergaard B; Schlemmer HP; Landgren O; Asmussen JT; Kaiser MF; Padhani A
    Radiology; 2019 Apr; 291(1):5-13. PubMed ID: 30806604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Learning curves in radiological reporting of whole-body MRI in plasma cell disease: a retrospective study.
    Negroni D; Cassarà A; Trisoglio A; Soligo E; Berardo S; Carriero A; Stecco A
    Radiol Med; 2021 Nov; 126(11):1451-1459. PubMed ID: 34309766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inter-observer agreement of baseline whole body MRI in multiple myeloma.
    Croft J; Riddell A; Koh DM; Downey K; Blackledge M; Usher M; Boyd K; Kaiser M; Messiou C
    Cancer Imaging; 2020 Jul; 20(1):48. PubMed ID: 32665028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
    Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
    Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.